NPPA issued a notification regarding fixation of the retail price of Paracetamol IP 500 mg + Phenylephrine Hydrochloride IP 5mg + Caffeine (Anhydrous) IP 30 mg + Diphenhydramine Hydrochloride IP 25 mg for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) For M/s Albert David Ltd. (Marketer)

Mar 10, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 06, 2025, issued a notification regarding fixation of the retail price of Paracetamol IP 500 mg + Phenylephrine Hydrochloride IP 5mg + Caffeine (Anhydrous) IP 30 mg + Diphenhydramine Hydrochloride IP 25 mg for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) For M/s Albert David Ltd. (Marketer).

The following has been stated: -

•Each film-coated tablet contains: Paracetamol IP 500 mg + Phenylephrine Hydrochloride IP 5mg + Caffeine (Anhydrous) IP 30 mg + Diphenhydramine Hydrochloride IP 25 mg for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) For M/s Albert David Ltd. (Marketer) and the retail price is 4.22 (Rs)

The detailed notification is given in the document below.

[Notification No. 19(4493)/2025/DP/NPPA/Div.II I/10120/2025]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT